What’s Going On With UroGen Pharma Stock Wednesday?
UtroGen shares traded lower Wednesday after the ODAC of the Food and Drug Administration voted against the benefit/risk of UGN-102 (mitomycin) for intravesical solution. read more
Read More
EXCLUSIVE: Congress Trading Ban Sees Huge Support In Reader Poll, Here’s The Percent That Say Let Them Keep Trading Stocks
A bill to ban Congress trading activity has been proposed. Do Benzinga readers support the end of the practice? read more
Expert Outlook: Manhattan Associates Through The Eyes Of 10 Analysts
Latest Ratings for MANH Date Firm Action From To Feb 2022 Rosenblatt Maintains Buy Jul 2021 Rosenblatt Maintains Buy May 2021 Benchmark Maintains Buy View More Analyst Ratings for MANH View the Latest Analyst Ratings read more
Beyond The Numbers: 19 Analysts Discuss Ncino Stock
Latest Ratings for NCNO Date Firm Action From To Jan 2022 Keybanc Maintains Overweight Jan 2022 Piper Sandler Maintains Overweight Jan 2022 Barclays Maintains Equal-Weight View More Analyst Ratings for NCNO View the Latest Analyst Ratings read more
Beyond The Numbers: 7 Analysts Discuss LPL Finl Hldgs Stock
Latest Ratings for LPLA Date Firm Action From To Feb 2022 Morgan Stanley Maintains Overweight Jan 2022 Morgan Stanley Maintains Overweight Jan 2022 UBS Maintains Buy View More Analyst Ratings for LPLA View the Latest Analyst Ratings read more
Expert Outlook: Victoria’s Secret Through The Eyes Of 17 Analysts
Latest Ratings for VSCO Date Firm Action From To Mar 2022 Wells Fargo Maintains Overweight Jan 2022 UBS Initiates Coverage On Neutral Dec 2021 Morgan Stanley Maintains Equal-Weight View More Analyst Ratings for VSCO View the Latest Analyst Ratings read more
AMD Takes On Nvidia With ‘Direct Shot’ At GPUs: Reviewer Says RX 9060 Could ‘Hit The Bullseye’
AMD stock has underperformed Nvidia stock in recent years. Things could change if AMD’s new graphic cards can help the company compete more against the giant. read more